Meta Platforms
META
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
LYEL Lyell Immunopharma
- 0.616
- +0.003+0.47%
Close Dec 23 16:00 ET
- 0.612
- -0.004-0.63%
Post 16:08 ET
179.85MMarket Cap-0.78P/E (TTM)
0.637High0.600Low788.57KVolume0.623Open0.613Pre Close488.17KTurnover0.36%Turnover RatioLossP/E (Static)292.16MShares3.25652wk High0.34P/B133.30MFloat Cap0.58252wk Low--Dividend TTM216.54MShs Float19.840Historical High--Div YieldTTM5.95%Amplitude0.582Historical Low0.619Avg Price1Lot Size
About Lyell Immunopharma Company
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
Company Profile
SymbolLYEL
Company NameLyell Immunopharma
Listing DateJun 17, 2021
Issue Price17.00
Founded2018
CEODr. Lynn Seely,M.D.
MarketNASDAQ
Employees224
Fiscal Year Ends12-31
Address201 Haskins Way
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-695-0677
Websitehttp://www.lyell.com
Company Executives
- Name
- Position
- Salary
- Dr. Lynn Seely,M.D.
- Director, President and Chief Executive Officer
- 2.65M
- Charles Newton
- Chief Financial Officer and Principal Accounting Officer
- 4.32M
- Stephen Hill
- Chief Operating Officer
- 3.11M
- Dr. Gary Lee, PhD
- Chief Scientific Officer
- 2.23M
- Matthew Lang
- Chief Business Officer
- 4.01M
- Richard D. Klausner
- Chairman of the Board
- 310.75K
- Dr. Sumant Ramachandra,M.D.,PhD
- Director
- --
- Dr. Elizabeth G. Nabel, M.D.
- Independent Director
- 293.25K
- William J. Rieflin
- Independent Director
- 301.75K
- Dr. Otis W. Brawley,M.D.
- Independent Director
- 290.75K
- Catherine J. Friedman
- Lead Independent Director
- 330.25K
- Robert Taylor Nelsen
- Independent Director
- 286.75K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.